Dr. Jaime Imitola, MD FAAN

MS prevalence in #Connecticut is very high and every Friday in #March, our team is increasing awareness to our @uconnhealth.bsky.social employees, staff and visitors. . #MSvisibl @mssociety.bsky.social @uconnhealth.bsky.social #MScafe

MS prevalence in #Connecticut is very high and every Friday in #March, our team is increasing awareness to our @uconnhealth.bsky.social employees, staff and visitors. . #MSvisibl @mssociety.bsky.social @uconnhealth.bsky.social #MScafe

🧪The #ACTRIMS forum always has a session dedicated to ECRs to give them the opportunity to showcase their research and build their network. Here's our exciting #ACTRIMS2025 young investigator session on emerging concepts in MS, covering basic, translational and clinical science. See you there!

AQP4-specific T cells determine lesion localization in the CNS in a model of NMOSD - Acta Neuropathologica Communications Neuromyelitis optica spectrum disorder (NMOSD) is a paradigmatic autoimmune disease of the central nervous system (CNS), in which the water channel protein Aquaporin-4 (AQP4) is targeted by a self-rea...

AQP4-specific T cells determine lesion localization in the CNS in a model of NMOSD

actaneurocomms.biomedcentral.com/articles/10....

Our current leaders made a pledge to use "common sense" in governing. As a clinician scientist and leaders, it is unclear to us, how cutting the NIH budget that helps millions of ALL #redandblue Americans sensible, justifiable and making ANY sense. @uconnhealth.bsky.social @nature.com

🧪
If I were Canadian PM I would immediately:

1. Create a new $15B science fund

2. Offer any credentialed US scientist funding for lab startup and replacement of NIH grants if they move to Canada

3. Immediate permanent residency

4. Citizenship after 2 years

Overnight a science superpower

Feb 1, is the start of our @uconnhealth.bsky.social awareness campaign for #early MS. Despite the advances,we still have unmet needs in #MS. Please share our #MS #awareness work published in @MSJ_Research and RT. @mssocietyuk.bsky.social @aanmember.bsky.social @stanfordneuro.bsky.social

A pro-inflammatory protein panel signature that accurately identified Long Covid in kids compared with controls

www.nature.com/articles/s41...

Welcome immigrants from X interested in science to the friendlier skies of @bsky.app, as documented by a new @nature.com survey (but you already knew that 😉)
"Bluesky is much better for science. There is much less toxicity, misinformation, and distractions."
www.nature.com/articles/d41...

It's been a busy time in the MS group in the Centre for Preventive Neurology! We've put together a newsletter to update where we're up to, opportunities to input into and take part in research, and highlight some of our fantastic PhD students. mailchi.mp/4672ff6ce37d...

Tolebrutinib nears the MS approval finish line - The MS Wire Tolebrutinib is a disease-modifying therapy on the brink of being approved to fight multiple sclerosis. Fingers crossed that it is.

Tolebrutinib on a fast track towards final FDA approval to treat #SPMS. #MS themswire.com/tolebrutinib...

Multiple Sclerosis: Glial Cell Diversity in Time and Space Glial cells and their subtypes are key drivers of lesion progression in multiple sclerosis with roles in both tissue damage and repair depending on the surrounding tissue environment and the function....

Happy holidays with a new review about what glial cells are doing in MS patholoy featuring latest developments and tools, thanks @kooistrasm.bsky.social for teaming up and putting this together - have fun reading: onlinelibrary.wiley.com/doi/10.1002/...

"CNS Vasculitis in Autoimmune Disease: MR Imaging Findings and Correlation with Angiography"

doi.org/10.3174/ajnr...

Stem cells head to the clinic: treatments for cancer, diabetes and Parkinson’s disease could soon be here More than 100 clinical trials put stem cells for regenerative medicine to the test. It’s a turning point for a field beset with ethical and political controversy.

Great Nature article building momentum to the transition of stem cells to the bedside, with this in mind @ISSCR
launched the first-of-its Kind Continuing Education Course on Stem Cell-Based Medicine, translation of stem cell is our next goal.

www.nature.com/articles/d41...

ISSCR Creates First-of-its Kind Continuing Education Course on Stem Cell-Based Medicine — International Society for Stem Cell Research Clinicians will soon gain access to trusted education on stem cell-based therapies through a new Continuing Education (CE) course developed by the International Society of Stem Cell Research (ISSCR). ...

I am very excited to be part of the International team building this first of its kind continuing medical education for physicians worldwide. #ISSCR
#Nature isscr.org/isscr-news/c...

Stem cells head to the clinic: treatments for cancer, diabetes and Parkinson’s disease could soon be here More than 100 clinical trials put stem cells for regenerative medicine to the test. It’s a turning point for a field beset with ethical and political controversy.

Great Nature article building momentum to the transition of stem cells to the bedside, with this in mind @ISSCR
launched the first-of-its Kind Continuing Education Course on Stem Cell-Based Medicine, translation of stem cell is our next goal.

www.nature.com/articles/d41...

“A mí me enseñaron que la salud es el paciente” Entrevista con Ana Judith Román, la primera mujer neuróloga en Puerto Rico

Neurology just lost a true legend and trailblazer.

Ana Judith Román-García (1930-2024)

The 1st female neurologist in Puerto Rico and one of the 1st Black women to complete a neurology residency
1/10
#NeuroSky #MedSky www.elnuevodia.com/noticias/loc...

Excited to share that our PI Vijay Kuchroo will be awarded the 2025 AAI-Thermo Fisher Meritorious Career Award, for outstanding research contributions to immunology. He’ll be presented the award & giving a lecture in Honolulu at the annual @immunologyaai.bsky.social meeting in May. 🧪
Congrats Vijay!

Catastrophic outcome of patients with a rebound after Natalizumab treatment discontinuation In this article, we presented four cases and analyzed the actual evidence of rebound after Natalizumab (NTZ) withdrawal, clinical and radiological features are discussed. We think it is important to ...

Rebound relapse after cessation of NTZ. Happened to me, still recovering 12 months on. Kesimpta has been the stabilising factor so far #MS #MultipleSclerosis #Natalizumab #Kesimpta #Ofatumumab

onlinelibrary.wiley.com/doi/full/10....

"Why does the brain need billions of neurons to process 10 bits/second? Why can we only think about one thing at a time?"
www.cell.com/neuron/fullt...

From The Unbearable Slowness of Being

Can a computer tell patients how their multiple sclerosis will progress?
patienttalk.org/can-a-comput...

A neurologist with 2 APOE4 copies tells us about his experience with #Alzheimers disease
washingtonpost.com/wellness/202...

First ever image of another multi-planet solar system captured by ESO Telescope

This can’t be repeated enough. MS is never inactive/not there. It is always vandalising our brains whether it is detectable by current methods or not.

This is the reason to treat it with a highly effective DMT and the full court press of lifestyle interventions as soon as poss.

www.sanofi.com/en/media-roo...

Please RT to all your friends.

YouTube video by NBC Connecticut UConn Health created a more inclusive way to identify signs of MS

www.youtube.com/watch?v=wuGE...

YouTube video by RealTalkMS Episode 358: VISBL-MS with Dr. Jaime Imitola

www.youtube.com/watch?v=9bGy...

YouTube video by NeurologyLive A Call to Action to Address Disparities in Multiple Sclerosis Care

www.youtube.com/watch?v=1qtl...